Literature DB >> 12916929

The development of Cutina lipogels and gel microemulsion for topical administration of fluconazole.

H M El Laithy1, K M F El-Shaboury.   

Abstract

The influence of the vehicle on the release and permeation of fluconazole, a topical antifungal drug dissolved in Jojoba oil was evaluated. Series of Cutina lipogels (Cutina CPA [cetyl palmitate], CBS [mixture of glyceryl stearate, cetearyl alcohol, cetyl palmitate, and cocoglycerides], MD [glyceryl stearate], and GMS [glyceryl monostearate]) in different concentrations as well as gel microemulsion were prepared. In-vitro drug release in Sorensen's citrate buffer (pH 5.5) and permeation through the excised skin of hairless mice, using a modified Franz diffusion cell, were performed. The rheological behavior and the apparent viscosity values for different gel bases were measured before and after storage under freezing conditions at -4 degrees C and were taken as measures for stability of network structure. Candida albicans was used as a model fungus to evaluate the antifungal activity of the best formula achieved. The results of in vitro drug release and its percutaneous absorption showed that the highest values from gel microemulsion were assured. The rheological behavior of the prepared systems showed pseudoplastic (shear-thinning) flow indicating structural breakdown of the existing intermolecular interactions between polymeric chains. Moreover, the stability study revealed no significant difference between viscosity before and after storage for different formulae except for CPA Cutina lipogel (using analysis of variance [ANOVA] test at level of significance.05). The antifungal activity of fluconazole showed the widest zone of inhibition with gel microemulsion. The gel microemulsion is an excellent vehicle for fluconazole topical drug delivery.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12916929      PMCID: PMC2751344          DOI: 10.1208/pt030435

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  16 in total

1.  Analysis of data on the medicament release from ointments.

Authors:  W I HIGUCHI
Journal:  J Pharm Sci       Date:  1962-08       Impact factor: 3.534

2.  Influence of supersaturation on the pharmacodynamic effect of bupranolol after dermal administration using microemulsions as vehicle.

Authors:  J Kemken; A Ziegler; B W Müller
Journal:  Pharm Res       Date:  1992-04       Impact factor: 4.200

3.  Kinetics of release and simulated absorption of methyl nicotinate from different ointment formulations: in vitro-in vivo correlations.

Authors:  N Realdon; E Ragazzi; M Dal Zotto; E Ragazzi
Journal:  Pharmazie       Date:  1996-02       Impact factor: 1.267

Review 4.  [Structure levels of ointment gels. New conceptions on molecular theoretical treatment of ointment structure].

Authors:  R Hüttenrauch
Journal:  Pharmazie       Date:  1970-03       Impact factor: 1.267

5.  Significance of vehicle composition. I. Relationship between topical vehicle composition, skin penetrability, and clinical efficacy.

Authors:  J Ostrenga; C Steinmetz; B Poulsen
Journal:  J Pharm Sci       Date:  1971-08       Impact factor: 3.534

6.  Vehicle design for a new topical steroid, fluocinonide.

Authors:  J Ostrenga; J Haleblian; B Poulsen; B Ferrell; N Mueller; S Shastri
Journal:  J Invest Dermatol       Date:  1971-05       Impact factor: 8.551

7.  [State of order, properties and dynamics of structure in shear-crystallized ointments (author's transl)].

Authors:  R Hüttenrauch; S Fricke; V Baumann
Journal:  Pharmazie       Date:  1982-01       Impact factor: 1.267

8.  [Which galenic bases are in use nowadays for skin treatment?].

Authors:  E Nürnberg
Journal:  Hautarzt       Date:  1978-02       Impact factor: 0.751

9.  Evaluation of correlation between selected rheological parameters of ointments and their in vitro release data.

Authors:  P Kasza; L Gyarmati
Journal:  Pharmazie       Date:  1978-08       Impact factor: 1.267

10.  Transparent oil-water gels.

Authors:  C Provost
Journal:  Int J Cosmet Sci       Date:  1986-10       Impact factor: 2.970

View more
  24 in total

1.  Heat and mass transfer scale-up issues during freeze-drying, III: control and characterization of dryer differences via operational qualification tests.

Authors:  S Rambhatla; S Tchessalov; Michael J Pikal
Journal:  AAPS PharmSciTech       Date:  2006-04-21       Impact factor: 3.246

2.  Fabrication of modified transport fluconazole transdermal spray containing ethyl cellulose and Eudragit RS100 as film formers.

Authors:  Mukesh C Gohel; Stavan A Nagori
Journal:  AAPS PharmSciTech       Date:  2009-05-22       Impact factor: 3.246

3.  Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms.

Authors:  Claudia Salerno; Adriana M Carlucci; Carlos Bregni
Journal:  AAPS PharmSciTech       Date:  2010-06-03       Impact factor: 3.246

4.  Treatment of cutaneous candidiasis through fluconazole encapsulated cubosomes.

Authors:  Vijay Prajapati; Aakanchha Jain; Richa Jain; Sanjeev Sahu; Dharm Veer Kohli
Journal:  Drug Deliv Transl Res       Date:  2014-12       Impact factor: 4.617

5.  Nanoparticle-in-gel system for delivery of vitamin C for topical application.

Authors:  Sanjukta Duarah; Ramya Devi Durai; VedhaHari B Narayanan
Journal:  Drug Deliv Transl Res       Date:  2017-10       Impact factor: 4.617

6.  Effect of formulation components on the in vitro permeation of microemulsion drug delivery system of fluconazole.

Authors:  Mrunali R Patel; Rashmin B Patel; Jolly R Parikh; Ajay B Solanki; Bharat G Patel
Journal:  AAPS PharmSciTech       Date:  2009-07-17       Impact factor: 3.246

7.  Formulation and Evaluation of in situ Gels Containing Clotrimazole for Oral Candidiasis.

Authors:  N M Harish; P Prabhu; R N Charyulu; M A Gulzar; E V S Subrahmanyam
Journal:  Indian J Pharm Sci       Date:  2009-07       Impact factor: 0.975

8.  A novel itraconazole bioadhesive film for vaginal delivery: design, optimization, and physicodynamic characterization.

Authors:  Nitin B Dobaria; A C Badhan; R C Mashru
Journal:  AAPS PharmSciTech       Date:  2009-07-24       Impact factor: 3.246

9.  Development of lapachol topical formulation: anti-inflammatory study of a selected formulation.

Authors:  Ana Amélia M Lira; Elizângela A Sester; André Luis M Carvalho; Ruth R Strattmann; Miracy M Albuquerque; Almir G Wanderley; Davi P Santana
Journal:  AAPS PharmSciTech       Date:  2008-01-25       Impact factor: 3.246

10.  Reprogramming of keratin biosynthesis by sulforaphane restores skin integrity in epidermolysis bullosa simplex.

Authors:  Michelle L Kerns; Daryle DePianto; Albena T Dinkova-Kostova; Paul Talalay; Pierre A Coulombe
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-27       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.